INO icon

Inovio Pharmaceuticals
INO

Overview Fund Activity

208 hedge funds and large institutions have $428M invested in Inovio Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
-5
Holders Change %
-2.35%
% of All Funds
3.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
62
Reduced
63
Closed
38
Calls
$15.5M
Puts
$18.2M
Net Calls
-$2.67M
Net Calls Change
+$4.22M

Top Buyers

1
State Street
State Street
Massachusetts
$66.4M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
$29.9M
3
WA
Wasatch Advisors
Utah
$24.6M
4
Rafferty Asset Management
Rafferty Asset Management
New York
$6.15M
5
Bank of America
Bank of America
North Carolina
$3.21M

Top Sellers

1
AA
ALPS Advisors
Colorado
$0
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$19M
3
GC
Guggenheim Capital
Illinois
$0
4
Voloridge Investment Management
Voloridge Investment Management
Florida
$0
5
Morgan Stanley
Morgan Stanley
New York
$2.62M
Name Holding Trade Value Shares
Change 		Shares
Change %
DFCM
226
Dark Forest Capital Management
Puerto Rico
– -$1K -7 Closed
HFS
227
Hantz Financial Services
Michigan
– -$1K -7 Closed
6 7 8 9
10